FDA classifies ceramic shoulder implants as medium risk

The Food and Drug Administration has officially classified a specific type of shoulder implant into Class II, meaning it carries a moderate level of regulatory oversight. This covers devices with a ceramic head that replaces part of the shoulder joint and a metal stem that anchors into the bone. The implant can be fixed in place using bone cement or without it.

Why it matters: This is mostly an administrative update that changes how these specific implants are regulated. For manufacturers, it means faster access to market and lower compliance costs compared to the Class III pathway. For patients, it signals that the FDA considers this technology sufficiently understood to warrant standard safety checks rather than the most rigorous review process reserved for unfamiliar or high-risk devices.

Who it affects

• Medical device manufacturers producing shoulder joint prostheses with ceramic heads and metal stems

---

This action was published by the Food and Drug Administration in the Federal Register; readers should check the original document for full regulatory details.

Agency: Health and Human Services Department, Food and Drug Administration
Source: Federal Register — read the official document